RetinaRisk API

The RetinaRisk API enables access to our clinically validated algorithm for hospitals, clinics, diabetes platforms, pharmaceuticals and health insurers in order to streamline eye screening, identify high-risk patients and provide more personalized care.

The API easily connects to your IT systems to facilitate risk stratification of diabetic patients, based on required risk factors. High-risk patients will be called in first for eye screening, enhancing the clinical safety of those patients, while low-risk patients may come less frequently, without compromising their clinical safety.

Connect to our developer portal!

Start exploring our API with ease at no cost

Visit the developer portal

Easy

The RetinaRisk API is easy to integrate and we offer support for every client.

Fast

The RetinaRisk API returns your calculation results in seconds from anywhere in the world.

Reliable

With 99.95% uptime, the RetinaRisk API is among the most reliable in the business.

Extensively

CLINICALLY VALIDATED

The RetinaRisk algorithm was developed by Dr. Einar Stefansson, Professor at the Department of Ophthalmology, University of Iceland and Dr. Arna Gudmundsdottir, Endocrinologist at the National Hospital Reykjavik, who have decades of experience in screening for diabetic retinopathy and treating diabetes. Our algorithm is based on extensive international research and has been clinically validated in over 25.000 diabetic patients in three continents and found to be robust.

Explore our research

Safe and Effective

The RetinaRisk algorithm was safe and effective in a diabetic screening program in an ophthalmology clinic over 5 years. The use of the program reduces the mean frequency of screening visits and liberates valuable time in ophthalmic practice to be used on high‐risk diabetic patients or other patient groups.
Svein Estil
Ophthalmologist, Norway

Provided valuable
support

We have used the RetinaRisk algorithm in human-grading and AI based grading. The algorithm has provided valuable contextual support in both scenarios. It provides an evidence-based medical perspective to the grader at the point of screening. This is extremely useful to the non-medical grader who may not have the clinical context to infer risk.
Steve Cook
Ophthalmologist, South Africa

It is a great decision support tool

Having used RetinaRisk for over 5 years, it beautifully allows me to demonstrate to my patients, how modulating key, modifiable risk factors like glycosylated hemoglobin and blood pressure control, can dramatically affect their sight. Additionally, it is a great decision support tool, helping to determine when patients with diabetes need to be re-evaluated in my office
A. Paul Chous
MA, OD, FAAO, Tacoma, WA